Pediculosis Capitis — Patent Landscape
4
Approved drugs
9
Active US patents
72/100
Avg vulnerability
—
Annual revenue covered
Originators in Pediculosis Capitis
Cliff calendar — next 15 years
3
26
1
27
1
29
1
33
1
34
2
35
Approved drugs ranked by patent estate
| Drug | Originator | Active patents | Avg vuln | Revenue | First cliff |
|---|---|---|---|---|---|
|
Lignospan Forte
Lidocaine Hydrochloride
|
Fresenius Kabi | 4 | 71 | — | 2026-07-24 |
|
Xeglyze
ABAMETAPIR
|
Hatchtech | 2 | 71 | — | 2026-10-28 |
|
Ovide
MALATHION
|
Taro | 2 | 75 | — | 2026-08-14 |
|
Natroba
SPINOSAD
|
Cipher | 1 | 70 | — | 2033-11-25 |
Most attackable patents
| Patent | Drug | Type | Vuln | Expiry |
|---|---|---|---|---|
| 8759401 | Lignospan Forte | method of use | 85 | 2026-07-24 |
| 7560445 | Ovide | method of use | 85 | 2027-02-01 |
| 7812163 | Xeglyze | method of use | 80 | 2026-10-28 |
| 8540665 | Lignospan Forte | method of use | 73 | 2029-10-22 |
| 9895388 | Natroba | method of use | 70 | 2033-11-25 |
| 7977324 | Ovide | formulation | 65 | 2026-08-14 |
| 10292389 | Xeglyze | method of use | 62 | 2034-12-17 |
| 9358338 | Lignospan Forte | method of use | 62 | 2035-04-27 |
| 9370622 | Lignospan Forte | method of use | 62 | 2035-09-28 |
Strongest defences
| Patent | Drug | Type | Vuln | Expiry |
|---|---|---|---|---|
| 9370622 | Lignospan Forte | method of use | 62 | 2035-09-28 |
| 9358338 | Lignospan Forte | method of use | 62 | 2035-04-27 |
| 10292389 | Xeglyze | method of use | 62 | 2034-12-17 |
| 7977324 | Ovide | formulation | 65 | 2026-08-14 |
| 9895388 | Natroba | method of use | 70 | 2033-11-25 |
| 8540665 | Lignospan Forte | method of use | 73 | 2029-10-22 |
| 7812163 | Xeglyze | method of use | 80 | 2026-10-28 |
| 7560445 | Ovide | method of use | 85 | 2027-02-01 |
| 8759401 | Lignospan Forte | method of use | 85 | 2026-07-24 |
Related
- Pediculosis Capitis — full disease profile
- AI Patent Landscape Report — type "pediculosis capitis" for an AI exec memo
- Company Patent Rankings
- Biosimilar Opportunity Scanner